| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |